JP2009541387A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009541387A5 JP2009541387A5 JP2009516965A JP2009516965A JP2009541387A5 JP 2009541387 A5 JP2009541387 A5 JP 2009541387A5 JP 2009516965 A JP2009516965 A JP 2009516965A JP 2009516965 A JP2009516965 A JP 2009516965A JP 2009541387 A5 JP2009541387 A5 JP 2009541387A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound according
- membered heteroaryl
- phenyl
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 13
- 108091007960 PI3Ks Proteins 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 4
- 125000001624 naphthyl group Chemical group 0.000 claims 4
- 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 claims 3
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 230000001404 mediated effect Effects 0.000 claims 3
- -1 biphenylyl Chemical group 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 102000001708 Protein Isoforms Human genes 0.000 description 6
- 108010029485 Protein Isoforms Proteins 0.000 description 6
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0612630.4A GB0612630D0 (en) | 2006-06-26 | 2006-06-26 | Organic compounds |
| GB0612630.4 | 2006-06-26 | ||
| PCT/EP2007/005599 WO2008000421A2 (en) | 2006-06-26 | 2007-06-25 | Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009541387A JP2009541387A (ja) | 2009-11-26 |
| JP2009541387A5 true JP2009541387A5 (enExample) | 2012-03-08 |
| JP4944954B2 JP4944954B2 (ja) | 2012-06-06 |
Family
ID=36803903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009516965A Expired - Fee Related JP4944954B2 (ja) | 2006-06-26 | 2007-06-25 | ホスファチジルイノシトール３−キナーゼ阻害剤としてのチアゾリルウレア誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7799810B2 (enExample) |
| EP (1) | EP2035413A2 (enExample) |
| JP (1) | JP4944954B2 (enExample) |
| KR (1) | KR20090024294A (enExample) |
| CN (1) | CN101479258A (enExample) |
| AU (1) | AU2007264033A1 (enExample) |
| BR (1) | BRPI0713784A2 (enExample) |
| CA (1) | CA2655568A1 (enExample) |
| GB (1) | GB0612630D0 (enExample) |
| MX (1) | MX2008016358A (enExample) |
| RU (1) | RU2009102270A (enExample) |
| WO (1) | WO2008000421A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0725888B2 (ja) | 1986-09-17 | 1995-03-22 | 旭化成工業株式会社 | エ−テルチオエ−テル−芳香族スルホン系共重合体及びその製造方法 |
| CA2735373A1 (en) | 2008-08-29 | 2010-03-04 | Topotarget A/S | Novel urea and thiourea derivatives |
| UA104147C2 (uk) | 2008-09-10 | 2014-01-10 | Новартис Аг | Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань |
| AU2009322187B2 (en) * | 2008-12-04 | 2015-02-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of CNS disorders |
| EP2397479A4 (en) | 2009-02-12 | 2012-08-01 | Astellas Pharma Inc | HETERO RING DERIVATIVE |
| EP2492269A4 (en) | 2009-10-19 | 2013-08-07 | Taisho Pharmaceutical Co Ltd | aminothiazole |
| CA2808435C (en) | 2010-08-10 | 2017-05-09 | Astellas Pharma Inc. | Heterocyclic compound |
| EP2663304B1 (en) * | 2011-01-11 | 2019-11-20 | Dimerix Bioscience Pty Ltd | Combination therapy |
| ES2661510T3 (es) | 2011-12-15 | 2018-04-02 | Novartis Ag | Uso de inhibidores de la actividad o función de PI3K |
| CA2925064A1 (en) * | 2013-10-17 | 2015-04-23 | Glaxosmithkline Intellectual Property Development Limited | Pi3k inhibitor for treatment of respiratory disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR038703A1 (es) * | 2002-02-28 | 2005-01-26 | Novartis Ag | Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3 |
| TW200519106A (en) * | 2003-05-02 | 2005-06-16 | Novartis Ag | Organic compounds |
| TWI334868B (en) * | 2003-06-03 | 2010-12-21 | Nippon Kayaku Kk | [1,2,4] triazoro [1,5-a] pyrimidine-2-ylurea derivative and use thereof |
| GB0320197D0 (en) * | 2003-08-28 | 2003-10-01 | Novartis Ag | Organic compounds |
| GB0423653D0 (en) | 2004-10-25 | 2004-11-24 | Piramed Ltd | Pharmaceutical compounds |
-
2006
- 2006-06-26 GB GBGB0612630.4A patent/GB0612630D0/en not_active Ceased
-
2007
- 2007-06-25 WO PCT/EP2007/005599 patent/WO2008000421A2/en not_active Ceased
- 2007-06-25 RU RU2009102270/04A patent/RU2009102270A/ru not_active Application Discontinuation
- 2007-06-25 US US12/308,338 patent/US7799810B2/en not_active Expired - Fee Related
- 2007-06-25 BR BRPI0713784-2A patent/BRPI0713784A2/pt not_active Application Discontinuation
- 2007-06-25 KR KR1020097001625A patent/KR20090024294A/ko not_active Ceased
- 2007-06-25 CA CA002655568A patent/CA2655568A1/en not_active Abandoned
- 2007-06-25 MX MX2008016358A patent/MX2008016358A/es not_active Application Discontinuation
- 2007-06-25 AU AU2007264033A patent/AU2007264033A1/en not_active Abandoned
- 2007-06-25 CN CNA2007800243105A patent/CN101479258A/zh active Pending
- 2007-06-25 EP EP07764829A patent/EP2035413A2/en not_active Withdrawn
- 2007-06-25 JP JP2009516965A patent/JP4944954B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009541387A5 (enExample) | ||
| JP2018524390A5 (enExample) | ||
| JP2010530431A5 (enExample) | ||
| JP2010532387A5 (enExample) | ||
| SE0402735D0 (sv) | Novel compounds | |
| JP2010532386A5 (enExample) | ||
| JP2007519649A5 (enExample) | ||
| JP2006509749A5 (enExample) | ||
| JP2017533930A5 (enExample) | ||
| JP2007507494A5 (enExample) | ||
| NO20071577L (no) | Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer | |
| DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
| NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
| IL205501A (en) | Preparation of preparations for the treatment of arthritis | |
| JP2006501201A5 (enExample) | ||
| JP2020097577A5 (enExample) | ||
| JP2019501879A5 (enExample) | ||
| NO20085271L (no) | Muscarin reseptoragonister som er effektive i behandling av smerte, Alzheimers sykdom og schizofreni | |
| JP2019505529A5 (enExample) | ||
| SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| CN115315423A (zh) | 取代芳基类化合物 | |
| EP4442321A3 (en) | Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor | |
| MA46268B1 (fr) | Dérivés de 5-[2-(pyridin-2-ylamino)-1 ,3-thiazol-5-yl]-2,3-dihydro-1h-isoindol-1-one et leur utilisation en tant qu'inhibiteurs doubles de phosphatidylinositol 3-kinase delta & gamma | |
| JP2014511865A5 (enExample) | ||
| WO2017104725A1 (ja) | 創傷治療剤 |